Utilising shade to optimize UV exposure for vitamin D by D. J. Turnbull & A. V. Parisi
Atmos. Chem. Phys., 8, 2841–2846, 2008
www.atmos-chem-phys.net/8/2841/2008/
© Author(s) 2008. This work is distributed under
the Creative Commons Attribution 3.0 License.
Atmospheric
Chemistry
and Physics
Utilising shade to optimize UV exposure for vitamin D
D. J. Turnbull and A. V. Parisi
Centre for Rural and Remote Area Health, University of Southern Queensland, Toowoomba, Queensland 4350, Australia
Received: 29 November 2007 – Published in Atmos. Chem. Phys. Discuss.: 16 January 2008
Revised: 7 April 2008 – Accepted: 9 May 2008 – Published: 2 June 2008
Abstract. Numerous studies have stated that humans need
to utilise full sun radiation, at certain times of the day, to as-
sist the body in synthesising the required levels of vitamin
D3. The time needed to be spent in the full sun depends on a
number of factors, for example, age, skin type, latitude, solar
zenith angle. Current Australian guidelines suggest exposure
to approximately 1/6 to 1/3 of a minimum erythemal dose
(MED), depending on age, would be appropriate to provide
adequate vitamin D3 levels. The aim of the study was to de-
termine the exposure times to diffuse solar UV to receive ex-
posures of 1/6 and 1/3 MED for a changing solar zenith angle
in order to assess the possible role that diffuse UV (scattered
radiation) may play in vitamin D3 effective UV exposures
(UVD3). Diffuse and global erythemal UV measurements
were conducted at ﬁve minute intervals over a twelve month
period for a solar zenith angle range of 4◦ to 80◦ at a lati-
tude of 27.6◦ S. For a diffuse UV exposure of 1/3 MED, solar
zenith angles smaller than approximately 50◦ can be utilised
for exposure times of less than 10min. Spectral measure-
ments showed that, for a solar zenith angle of 40◦, the UVA
(315–400nm) in the diffuse component of the solar UV is
reduced by approximately 62% compared to the UVA in the
global UV, whereas UVD3 wavelengths are only reduced by
approximately 43%. At certain latitudes, diffuse UV under
shade may play an important role in providing the human
body with adequate levels of UVD3 (290–315nm) radiation
without experiencing the high levels of UVA observed in full
sun.
Correspondence to: D. J. Turnbull
(turnbull@usq.edu.au)
1 Introduction
The health effects of solar UV radiation vary signiﬁcantly,
from initiating the synthesis of vitamin D3 to the severe
degradation of the human body. Excessive solar UV radia-
tion exposure led to the premature deaths of approximately
60000 people in the year 2000 (Lucas et al., 2006). It is well
known that exposure to small amounts of UV radiation are
beneﬁcial for the human body and important in the produc-
tion of vitamin D3, whereas excessive exposure to sunlight is
knowntocauseskincancer, immunesuppression, DNAdam-
age, erythema and sun-related eye disorders (Baron et al.,
2003; Glerup et al., 2000; Terenetskaya, 2000; Sliney, 2004;
Setlow et al., 1993). Approximately 90–95% of our vita-
min D3 requirement comes from exposure to the sun (Holick,
2004; Holick, 1998). The synthesis of pre-vitamin D3 is ini-
tiated through exposure of human skin to terrestrial UV radi-
ation from 290 to 315nm. The longer wavelength UV radi-
ation (greater than 315nm) plays no part in the synthesis of
pre-vitamin D3 in humans. Although, over exposure to UV
wavelengths is known to cause damage, vitamin D3 synthe-
sis occurs at doses far below those needed for erythema to
arise (Webb, 1993). Small amounts of vitamin D3 can also
be obtained from some foods, for example oily ﬁsh and eggs
or by fortifying foods with vitamin D3. It has been shown
that the vitamin D3 from these sources cannot provide sufﬁ-
cient vitamin D3 for the elderly (Mosekilde, 2005). Vitamin
D3 can also be obtained through vitamin tablets; however the
simplest way to obtain vitamin D3 is from moderate expo-
sure to sunlight (Holick, 2004). Furthermore, this is also the
cheapest way without the cost burden of vitamin tablets.
Current Australian guidelines suggest exposure to approx-
imately 1/6 to 1/3 of a MED (minimum erythemal dose), de-
pending on age, would be appropriate to provide adequate
vitamin D3 levels (Samanek et al., 2006; CDHAA, 2004).
Older people require more frequent exposures as vitamin D3
production rates are about 1/5 as high for the elderly as for
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the young (Holick et al., 1989). Also, people with highly pig-
mented skin would require exposures 3–4 times greater than
those necessary for fair skinned people (Pathak et al., 1999).
Recent research suggests that the optimal serum vitamin D3
level for bone health and protection against other diseases is
between 800 and 2000 IU per day (Aloia and Li-Ng, 2007;
Lappe et al., 2007; Vieth et al., 2007; Dawson-Hughes et
al., 2005); with 1000 IU equivalent to exposing 15% of the
human body to approximately 1/3 MED (PS, 2006). A posi-
tion statement was recently approved by the Working Group
of the Australian and New Zealand Bone and Mineral So-
ciety, Endocrine Society, Osteoporosis Australia, Australian
College of Dermatologists and the Cancer Council Australia
recommending ﬁve minutes solar UV exposure either side
of the peak UV periods on most days of the week in sum-
mer and approximately 2–3h solar UV exposure over a week
in winter (PS, 2006). This position statement is still behind
emerging scientiﬁc ﬁndings (e.g. Giovannucci et al., 2006;
Grant et al., 2007; Gorham et al., 2007; Garland et al., 2007).
Nevertheless, it is still the most up to date statement that has
been distributed to the public. The position statement is also
a generalized report as sun exposure varies signiﬁcantly with
latitude and atmospheric conditions.
Solar UV radiation is incident on the earth’s surface in two
distinct components, direct and diffuse. The direct compo-
nent is straight forward to minimise by simply blocking its
path, whereas the diffuse component is incident from all di-
rections and is difﬁcult to minimise. Atmospheric scatter-
ing which is inﬂuenced by factors such as solar zenith angle
(SZA), clouds and atmospheric constituents plays a major
role in determining the proportions of UVB (280–315nm)
and UVA (315–400nm) in diffuse UV, with greater scatter-
ing occurring at the shorter UVB wavelengths than at the
longer wavelength UVA. Turnbull et al. (2005) found that
UVA was reduced by as much as 65% when utilising a shade
umbrella, whereas UVB exposures were only reduced by ap-
proximately 48%. Therefore, at certain SZA, the diffuse
UV may provide adequate levels of the effective wavelengths
needed for vitamin D3 production (UVD3), without produc-
ing erythema. In comparison, mutagenic and carcinogenic
effects on human skin have been shown to be caused by ex-
posure to UVA radiation (Agar et al., 2004; Moan et al.,
1999; Garland et al., 2003). Therefore, reducing personal
exposures to UVA radiation while still receiving sufﬁcient
amounts of the UVD3 wavelengths required to produce rec-
ommended vitamin D3 levels is essential.
The importance of this research is that it provides a basis
for public health campaigns aimed at reducing the incidence
of hypovitaminosis D and its attendant disorders, as well as
reducing over exposure to harmful solar UV radiation. In
the light of the considerable body of evidence regarding the
harm done by excessive UV exposure and the public aware-
ness of skin cancer, any new public health program would
need to avoid confusing the public with seemingly oppos-
ing messages. Utilizing diffuse solar UV radiation to obtain
beneﬁcial amounts of UV, while at the same time minimiz-
ing personal overexposure to UVA radiation may prove to
be absolutely necessary for an improvement in public health.
Studies have shown that shade structures are important as a
UV minimisation strategy; however, shade settings may also
play an important role in providing exposures to the human
body with adequate levels of UV radiation for vitamin D3
production without experiencing the higher levels of UVA
experienced in full sun. The lengths of exposure to solar UV
at noon in major Australian cities to produce exposures of
1/3 and 1/6 MED has previously been reported (Samanek et
al., 2006). Shade as a protective device has been discussed
numerous times before (e.g. Turnbull and Parisi, 2006) and
it is not the aim of this paper. This current paper is about the
exposures that humans may receive when utilising solar UV
for vitamin D3 synthesis and the possible methods to opti-
mise this radiation. The author’s are unaware of any similar
research or attempts to show how solar UV exposures can be
optimised so humans can receive adequate vitamin D3 levels
as well as reducing their total UV exposure.
2 Materials and methods
2.1 Integrated automated cloud and spectral UV measure-
ment system
An integrated automated cloud and spectral UV measure-
ment system was employed at a Southern Hemisphere site at
Toowoomba, Australia (27.6◦ S, 151.9◦ E, 693m above sea
level) for automatically measuring every ﬁve minutes both
the cloud fraction and the UV spectrum. The system was lo-
cated on the roof of a building with relatively unobstructed
views and the surrounding topography does not provide any
signiﬁcant obstruction to the ﬁeld of view of the instruments.
The cloud detection system is a Total Sky Imager (TSI)
(model TSI-440, Yankee Environmental Systems, MA,
USA) with approximately 160◦ ﬁeld of view of the sky.
The TSI consists of a CCD camera suspended over a hemi-
spherical reﬂective dome that points upwards on a horizontal
plane. For each image, digital analysis provides the fraction
of cloud cover as a number between 0 and 1 where 1 repre-
sents total cloud cover. The uncertainty in the determination
of the amount of cloud has been reported as ±10% at least
95% of the time (Sabburg and Long, 2004).
The spectral UV measurement system is located within
three metres of the cloud detection system and is housed in
an environmentally sealed box with a ﬁbre optic connecting
the diffuser to the input slit of the monochromator through
a hole with a seal around the ﬁbre to protect the equipment
inside the box from the environment. The system is based
on a double monochromator system model (DTM300, Ben-
tham Instruments, Reading, UK) with the gratings having
2400grooves/mm. The input and output slit widths on the
monochromator of 0.37mm have been selected to provide a
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bandwidth of 0.5 nm. The spectral UV data was recorded
from 280 to 400nm in 0.5nm increments. The input optics
are provided by a diffuser (model D6) with the manufacturer
determined error associated with the cosine response as less
than ±0.8% for a SZA up to 70◦ and ±3.3% for an SZA
of 80◦. The system is scheduled to scan every ﬁve minutes
from 05:00EST (Eastern Standard Time) to 17:00EST and
the start of the initialisation of a spectral scan is one minute
before the TSI obtains an image of the sky. This allows the
spectral scan to start at approximately the same time that the
TSI takes the sky image. Wavelength and irradiance calibra-
tion of the spectral UV system was undertaken by employing
the 365nm mercury spectral line and a 150Watt quartz halo-
gen lamp with calibration traceable to the National Physical
Laboratory, UK standard.
2.2 Diffuse and global erythemal UV
Two erythemal UV meters (UV-Biometer Model 501, Solar
Light Co., Philadelphia, PA. USA) were employed to moni-
tor the diffuse and global erythemal UV (UVery). The diffuse
UVery meter is a global UVery meter that has been specif-
ically set up to measure the diffuse erythemal radiation. It
utilizes a shadow band, which is aligned east-west, to block
the sun during the day. The shadow band is 0.076m wide
and the distance from the shadow band to the top of the dif-
fuse UVery meter varies from 0.25m to 0.27m as it is moved
with the seasons. The shadow band blocks out part of the
sky view and the amount blocked has been measured at ap-
proximately 10%. A correction has been applied to all of the
data to account for this. The diffuse and global UVery me-
ters were set up to record data every ﬁve minutes. The me-
ters are temperature stabilized to 25◦C and calibrated twice
a year during clear sky conditions against the scanning spec-
troradiometer. The daily atmospheric column of ozone as
obtained from the TOMS (Total Ozone Mapping Spectrom-
eter) ranged from 243.5 to 337.0DU and the SZA ranged
from 4◦ to 80◦ over the twelve month measurement period
from January to December 2003.
3 Results
3.1 Diffuse and global erythemal UV
An example of diffuse and global UV spectra is shown
in Fig. 1a for a cloud free period on 17 August 2005 at
11:55EST for an SZA of 40◦. This illustrates the varia-
tion in the relative proportions of the different wavelengths
when comparing diffuse UV to global UV. For Fig. 1a, the
diffuse spectral irradiance summed over the UVA waveband
was 16.8W/m2 compared to 44.5W/m2 for the global UVA.
Similarly, the diffuse UVB was 0.63W/m2 compared to
1.12W/m2 for global UVB. For this speciﬁc date and time,
the UVA was reduced by approximately 62% compared to
the global UVA, whereas the diffuse UVB was only reduced
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Figure 1. Diffuse (light line) and global (heavy line) spectral UV irradiances taken on 17 August 
2005 at approximately 11:00 EST and the spectral ratio of diffuse to global UV (a); and global and 
diffuse spectral irradiances from (a) weighted with the pre-vitamin D3 action spectrum (CIE, 2006).  
 
Fig. 1. Diffuse (light line) and global (heavy line) spectral UV irra-
diances taken on 17 August 2005 at approximately 11:00EST and
the spectral ratio of diffuse to global UV (a); and global and diffuse
spectral irradiances from Fig. 1a weighted with the pre-vitamin D3
action spectrum (CIE, 2006) (b).
by approximately 44%. The ratio of the diffuse to global UV
plotted on the right hand axis of Fig. 1b gives an indication
of the change in ratio when comparing global and diffuse UV
wavelengths.
Figure 1b provides the global and diffuse solar UV spectra
(from Fig. 1a) weighted with the pre-vitamin D (CIE, 2006)
action spectrum. Pre-vitamin D3 exposure was reduced by
43% whereas UVA exposure was reduced by 64%. These
spectral measurements were obtained using the spectral mea-
surement system described earlier.
3.2 Exposure times for 1/3 MED
The times required for an exposure of 1/3 MED on a hori-
zontal plane for SZA greater than 4◦ for the atmospheric and
cloud conditions during 2003 are shown in Fig. 3a for dif-
fuse and Fig. 3b for global UVery. Over 25000 data points
are provided in each ﬁgure for diffuse and global UVery for
all SZA, sky and atmospheric conditions encountered over
this period. The average times for an exposure equivalent to
1/3 MED for vitamin D3 and erythema are shown in Table 1
for diffuse and global UV. For a SZA of 5◦, the average time
needed to receive an exposure of 1/3 MED due to erythemal
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Table 1. Average times for an exposure equivalent to 1/3 MED for vitamin D3 and erythemal effective UV radiation.
Global UVD3 Diffuse UVD3 Global UVery Diffuse UVery
SZA (min) (min) (min) (min)
5◦ 2.2 (0.8) 3.2 (0.5) 4.4 (2.5) 6.8 (2.8)
15◦ 2.5 (3.4) 3.9 (3.1) 5.1 (5.9) 7.7 (5.2)
25◦ 2.8 (1.8) 4.5 (2.6) 6.0 (4.5) 8.7 (4.0)
35◦ 3.5 (2.0) 5.2 (2.5) 7.1 (4.2) 10.2 (4.3)
45◦ 5.7 (3.8) 7.1 (3.1) 10.8 (6.6) 13.7 (5.4)
55◦ 10.1 (5.9) 13.2 (7.7) 19.9 (16.5) 24.2 (16.3)
65◦ 27.5 (19.0) 27.2 (17.2) 42.0 (30.8) 43.6 (25.1)
75◦ 103.3 (63.5) 97.7 (47.7) 110.3 (56.3) 111.6 (49.3)
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Figure 2. The times required for an exposure of 1/3 MED due to diffuse UVery (a) and global UVery 
(b) as a function of SZA for all sky conditions during 2003. 
 
  
Fig. 2. The times required for an exposure of 1/3 MED due to dif-
fuse UVery (a) and global UVery (b) as a function of SZA for all
sky conditions during 2003.
UV was 4.4 and 6.8min for global and diffuse respectively.
Whereas, the average time needed to receive an equivalent
exposure of 1/3 MED for vitamin D3 production was 2.2 and
3.2min for global and diffuse respectively. These times are
based on exposing 15% of the human body to UV radiation.
Increasing the exposed body surface will subsequently de-
crease the time needed for vitamin D3 production (e.g. ex-
posing three times more body surface will reduce the expo-
sure times presented in this research by a factor of three).
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Figure 3. Times for exposure to 1/3 MED of diffuse UV for cloud cover of 0 to 80% (a) and 85 to 
100% (b).  Fig. 3. Times for exposure to 1/3 MED of diffuse UV for cloud
cover of 0 to 80% (a) and 85 to 100% (b).
However, the time for 1/3 MED of erythemal effective UV
will remain the same.
As shown in Fig. 3a and b, this data has been broken down
into separate cloud levels of 0 to 80% and 85 to 100%, re-
spectively. This was undertaken to illustrate that 0 to 80% of
cloud cover has a lesser effect on the diffuse UV compared
to 85 to 100% of cloud.
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The times required for an exposure of 1/3 MED due to
the diffuse and global UVery on a horizontal plane expressed
as a percentage of occurrence for 2003 are shown in Fig. 4.
For diffuse UVery, the maximum incidence for 1/3 MED was
in the range of 5 to 10min with an occurrence of 34.9%, fol-
lowedby29.5%for10to15min, and17.8%for15to20min.
For global UVery, the maximum incidence of the times for
1/3 MED was in the range of 5 to 10min with an occurrence
of 32.9%, followed by 26.7% for less than or equal to 5min,
and 17.9% for 10 to 15min.
4 Discussion
Studies on the levels of UV observed in the shade of different
shade environments have shown that the relative proportions
of UVA and UVB in the shade are signiﬁcantly different to
those in full sun (Turnbull et al., 2005; Turnbull and Parisi,
2003; Turnbull et al., 2003; Parisi et al., 2001). The relative
proportions of the UVA in shade to those in full sun are de-
creased compared to the relative proportions of the UVB in
shade to those in full sun. At certain latitudes and SZA, un-
protected exposure for short periods to the UV under shade
structures may be the best course of action as it will con-
tribute more toward vitamin D3 production than toward ery-
thema compared to exposing the body to full sun UV due to
the reduced relative component of the UVA in the shade.
The average time for an exposure of 1/3 MED due to dif-
fuse UVery was 6.8min for a SZA of 5◦. Whereas, the av-
erage time needed to receive an equivalent exposure of 1/3
MED for vitamin D3 production was only 3.2min. These
times are longer for larger SZA and for overcast conditions.
For an exposure of 1/3 MED, SZA smaller than approxi-
mately 50◦ can be utilised for exposure times of less than
10min. For SZA between 4◦ to 50◦, 94% of the data shows
that an exposure of 1/3 MED requires less than 20min of ex-
posure to diffuse UV. Although the measurements are at one
latitude, the data was collected for the SZA range of 4◦ to
80◦. This will allow the results to be applicable at latitudes
that experience these SZA.
The values provided in this paper are for pale skin and for
a sky view that is not blocked, apart from the blocking of the
solar disc. However, research is currently being conducted
beneath various shade environments and initial results show
that shade environments of at least 50% sky view exhibit ex-
cellent correlation with the values shown in Fig. 2a. For ex-
ample, at approximately 18◦ SZA the average time for 1/3
MED from diffuse UVery on a horizontal plane is approxi-
mately 7.5min. Initial results for the same SZA show that
the times for 1/3 MED in the shade of a shade umbrella and
on the southern side of a building were approximately 7min
and 9min respectively. For larger structures the amount of
sky view will be reduced due to the structural components
of the shade structure, causing the exposure times required
for the respective exposures due to the diffuse UVery to be
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Figure 4. The percentage of instances when the time required for an exposure of 1/3 MED due to 
diffuse (grey bar) and global (black bar) UVery falls within a certain time range (provided in units of 
minutes).    Fig. 4. The percentage of instances when the time required for an
exposure of 1/3 MED due to diffuse (grey bar) and global (black
bar) UVery falls within a certain time range (provided in units of
minutes).
slightly longer. Nevertheless, the ﬁndings in this paper may
have signiﬁcant ramiﬁcations for future public health policy
regarding sun exposure, which is currently being debated in
many countries (Diffey, 2006; Gillie, 2006). Also, the ﬁnd-
ingsofthisresearchmayproveusefultothosethatworkfrom
9a.m. to 5p.m., where solar UV exposure at noon or during
a lunch break may be the only option for the necessary UV
exposures to initiate the synthesis of vitamin D3. Therefore,
advice to stay out of the sun in the middle of the day, which
is best for vitamin D3 synthesis in the skin, can be adjusted to
advocate the possible use of appropriate shade environments.
However, in the shade there is the potential danger due to
the ﬁltering of the infrared waveband, which may cause pro-
longed exposures.
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